These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24343870)

  • 1. An extension of the placebo-based pattern-mixture model.
    Lu K
    Pharm Stat; 2014; 13(2):103-9. PubMed ID: 24343870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analytic method for the placebo-based pattern-mixture model.
    Lu K
    Stat Med; 2014 Mar; 33(7):1134-45. PubMed ID: 24122822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power calculations for delta-adjusted pattern-mixture models.
    Lu K
    Stat Med; 2015 Feb; 34(5):782-95. PubMed ID: 25395021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
    Mallinckrodt CH; Lin Q; Molenberghs M
    Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A latent-class mixture model for incomplete longitudinal Gaussian data.
    Beunckens C; Molenberghs G; Verbeke G; Mallinckrodt C
    Biometrics; 2008 Mar; 64(1):96-105. PubMed ID: 17608789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of pattern mixture models to address missing data in longitudinal data analysis using SPSS.
    Son H; Friedmann E; Thomas SA
    Nurs Res; 2012; 61(3):195-203. PubMed ID: 22551994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian pattern-mixture models for dropout and intermittently missing data in longitudinal data analysis.
    Blozis SA
    Behav Res Methods; 2024 Mar; 56(3):1953-1967. PubMed ID: 37221346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
    Yang M; Maxwell SE
    Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of missing data on type 1 error rates in non-inferiority trials.
    Yoo B
    Pharm Stat; 2010; 9(2):87-99. PubMed ID: 19408241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusting for nonignorable missingness when estimating generalized additive models.
    Xie H
    Biom J; 2010 Apr; 52(2):186-200. PubMed ID: 20422637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models.
    Ratitch B; O'Kelly M; Tosiello R
    Pharm Stat; 2013; 12(6):337-47. PubMed ID: 23292975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pattern-mixture model with nonfuture dependence and shift in current missing values.
    Lu K; Chen C; Li D
    J Biopharm Stat; 2015; 25(3):548-69. PubMed ID: 24905193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short notes on maximum likelihood inference for control-based pattern-mixture models.
    Tang Y
    Pharm Stat; 2015; 14(5):395-9. PubMed ID: 26178475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An application of the mixed-effects model and pattern mixture model to treatment groups with differential missingness suspected not-missing-at-random.
    Gosho M; Maruo K
    Pharm Stat; 2021 Jan; 20(1):93-108. PubMed ID: 33249763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Two-Step Approach for Analysis of Nonignorable Missing Outcomes in Longitudinal Regression: an Application to Upstate KIDS Study.
    Liu D; Yeung EH; McLain AC; Xie Y; Buck Louis GM; Sundaram R
    Paediatr Perinat Epidemiol; 2017 Sep; 31(5):468-478. PubMed ID: 28767145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missing data sensitivity analysis for recurrent event data using controlled imputation.
    Keene ON; Roger JH; Hartley BF; Kenward MG
    Pharm Stat; 2014; 13(4):258-64. PubMed ID: 24931317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A characterization of missingness at random in a generalized shared-parameter joint modeling framework for longitudinal and time-to-event data, and sensitivity analysis.
    Njagi EN; Molenberghs G; Kenward MG; Verbeke G; Rizopoulos D
    Biom J; 2014 Nov; 56(6):1001-15. PubMed ID: 24947904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonignorable models for intermittently missing categorical longitudinal responses.
    Tsonaka R; Rizopoulos D; Verbeke G; Lesaffre E
    Biometrics; 2010 Sep; 66(3):834-44. PubMed ID: 19995352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.